OMERS Administration Corp’s RAPT Therapeutics RAPT Stock Holding History

OMERS Administration Corp’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,600	Closed	-$393K	–	1155
2025 Q4	$393K	Buy	+11,600	New	+$360K	﹤0.01%	747

OMERS Administration Corp's RAPT Position: Q1 2026 in Review

OMERS Administration Corp sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 11,600 shares — an estimated $393K sold.

OMERS Administration Corp first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $393K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

OMERS Administration Corp reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
OMERS Administration Corp sold 11,600 RAPT Therapeutics shares in Q1 2026, an estimated $393K.
OMERS Administration Corp first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
OMERS Administration Corp's RAPT Therapeutics position peaked at $393K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.